Neutron therapy for salivary and thyroid gland cancer

Journal Article · Tue Aug 02 00:00:00 EDT 2016 · AIP Conference Proceedings

DOI:https://doi.org/10.1063/1.4960240· OSTI ID:22608277

Gribova, O. V., E-mail: [e-mail]; Choynzonov, E. L., E-mail: [e-mail] ^[1]; National Research Tomsk Polytechnic University, Lenina Avenue 30, Tomsk, 634050 ^[2]; Musabaeva, L. I., E-mail: [e-mail]; Lisin, V. A., E-mail: [e-mail]; Novikov, V. A., E-mail: [e-mail] ^[1]

---

1. Tomsk Cancer Research Institute, Kooperativny Street 5, Tomsk, 634050 (Russian Federation)
2. (Russian Federation)

The purpose of this study was to analyze the results of the combined modality treatment and radiation therapy using 6.3 MeV fast neutrons for salivary gland cancer and prognostically unfavorable thyroid gland cancer. The study group comprised 127 patients with salivary gland cancer and 46 patients with thyroid gland cancer, who received neutron therapy alone and in combination with surgery. The results obtained demonstrated that the combined modality treatment including fast neutron therapy led to encouraging local control in patients with salivary and thyroid gland cancers.

• OSTI ID: 22608277
• Journal Information: AIP Conference Proceedings, Vol. 1760, Issue 1; Conference: PC'16: International conference on physics of cancer: Interdisciplinary problems and clinical applications 2016, Tomsk (Russian Federation), 22-25 Mar 2016; Other Information: (c) 2016 Author(s); Country of input: International Atomic Energy Agency (IAEA); ISSN 0094-243X
• Country of Publication: United States
• Language: English

Related Subjects

62 RADIOLOGY AND NUCLEAR MEDICINE
FAST NEUTRONS
MEV RANGE 01-10
NEOPLASMS
NEUTRON BEAMS
NEUTRON THERAPY
PATIENTS
SALIVARY GLANDS
SURGERY
THYROID